Jacques Dumas, Chief Scientific Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 17,500 shares at $6.00 ($105K) on 2017-08-22, disclosed to the SEC on 2017-08-24.
Open-market sale of $105k TTPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTPH | SELL | 2018-01-11 | $45K | — | Filing → |
| TTPH | SELL | 2017-11-02 | $106K | — | Filing → |
| TTPH | SELL | 2017-08-21 | $42K | — | Filing → |